Polyether antibiotic CP44,161

The crystal structure of antibiotic CP44,161, 6-(7-{2-ethyl-2-[5-(1-hydroxy­methyl)-5-methyl-2,3,4,5-tetra­hydro-2-furyl]-4,10,-­12-tri­methyl-1,6,8-trioxadi­spiro­[4.1.5.3]­pentadec-13-en-9-yl}-4-hydroxy-3,5-di­methyl-6-oxononyl)-2-hydroxy-3-methyl­benzoic acid monohydrate, C₄₃H₆₆O₁₀·H₂O, has been determined by X-ray crystallography. The mol­ecule adopts a cyclic conformation, with a centrally located water mol­ecule contributing to the stability of the conformation through hydrogen-bonding interactions.     

Four bromo‐substituted pyrazoline and isoxazolinone spiro derivatives

Conformational analyses and a structural comparison of the four spiro compounds 3‐bromo‐1,9‐di­phenyl‐4‐p‐tolyl‐7‐oxa‐1,2,8‐tri­aza­spiro­[4.4]­nona‐2,8‐dien‐6‐one, (I), C₂₄H₁₈BrN₃O₂, 3‐bromo‐4‐(4‐methoxy­phenyl)‐1,9‐di­phenyl‐7‐oxa‐1,2,8‐tri­aza­spiro­[4.4]­nona‐2,8‐dien‐6‐one, (II), C₂₄H₁₈BrN₃O₃, 3‐bromo‐4‐(4‐chloro­phenyl)‐1,7,9‐tri­phenyl‐1,2,7,8‐tetra­aza­spiro­[4.4]­nona‐2,8‐dien‐6‐one, (III), C₂₉H₂₀BrClN₄O, and 3‐bromo‐1,7,9‐tri­phenyl‐4‐p‐tolyl‐1,2,7,8‐tetra­aza­spiro­[4.4]­nona‐2,8‐di­en‐6‐one, (IV), C₃₀H_22.89Br_1.11N₄O, are presented. The mol­ecular structures are rather similar, which is as expected since the compounds are all products of concerted 1,3‐dipolar attack on (Z)‐4‐aryl­idene oxazolone and pyrazolone derivatives. The observed conformations tend to favour extended π conjugation of the benzene rings and other π systems, as shown by a comparison of selected geometric parameters of the four structures.     

KNI-272, a highly selective and potent peptidic HIV protease inhibitor

Kynostatin {KNI-272; systematic name: 3-[3-benzyl-2-hydroxy-9-(isoquinolin-5-yl­oxy)-6-methyl­sulfanyl­methyl-5,8-dioxo-4,7-di­aza­nonanoyl]-N-tert-butyl-1,3-thia­zolane-4-carbox­amide}, a highly selective and potent HIV protease inhibitor containing allo­phenyl­norstatin [(2S,3S)-3-amino-2-hydroxy-4-phenyl­butyric acid], has been crystallized as the hydrate, C₃₃H₄₁N₅O₆S₂·0.803H₂O, from aqueous hexyl­ene glycol. The observed disorder of the phenyl group in the structure is related to the mode of hydration. The backbone conformation of the mol­ecule is twisted and the overall conformation of the free inhibitor is similar to that observed in its complex with HIV protease.     

Two (E,E)- and (Z,E)-thiazol-5-ylpenta-2,4-dienones

In order to characterize the structural elements that might play a role in non-covalent DNA binding by the antitumor antibiotic leinamycin, we have solved the crystal structures of the two leinamycin analogs, methyl (R)-5-{2-[1-(tert-butoxy­carbonyl­amino)­ethyl]­thia­zol-4-yl}penta-(E,E)-2,4-dienoate, C₁₆H₂₂N₂O₄S, (II), and 2-methyl-8-oxa-16-thia-3,17-di­aza­bicyclo­[12.2.1]­heptadeca-(Z,E)-1(17),10,12,14-tetraene-4,9-di­one, C₁₄H₁₆N₂O₃S, (III). The penta-2,4-dienone moiety in both of these analogs adopts a conformation close to planarity, with the thia­zole ring twisted out of the plane by 12.9 (2)° in (II) and by 21.4 (4)° in (III).     

Four cyclo­alkane­spiro‐4′‐imidazolidine‐2′,5′‐dithiones

The crystal structures of four cyclo­alkane­spiro‐4′‐imidazolidine‐2′,5′‐dithiones, namely cyclo­pentane­spiro‐4′‐imidazolidine‐2′,5′‐dithione {systematic name: 1,3‐diaza­spiro­[4.4]­nonane‐2,4‐dithione}, C₇H₁₀N₂S₂, cyclo­hexane­spiro‐4′‐imidazolidine‐2′,5′‐dithione {systematic name: 1,3‐diaza­spiro­[4.5]decane‐2,4‐dithione}, C₈H₁₂N₂S₂, cyclo­heptane­spiro‐4′‐imidazolidine‐2′,5′‐dithione {systematic name: 1,3‐diaza­spiro­[4.6]undecane‐2,4‐dithione}, C₉H₁₄N₂S₂, and cyclo­octane­spiro‐4′‐imidazolidine‐2′,5′‐dithione {systematic name: 1,3‐di­aza­spiro­[4.7]dodecane‐2,4‐dithione}, C₁₀H₁₆N₂S₂, have been determined. The three‐dimensional packing in all of the structures is based on closely similar chains, in which hydantoin moieties are linked through N—H⋯S hydrogen bonding. The size of the cyclo­alkane moiety influences the degree of its deformation. In the cyclo­octane compound, the cyclo­octane ring assumes both boat–chair and boat–boat conformations.     

Two 5‐oxa‐2,6‐diazaspiro[3.4]octan‐1‐one derivatives from the [3+2] cyclo­addition of methylenelactams with nitrones

The two title 5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one adducts, 7‐benzoyl‐2‐(4‐methoxy­phenyl)‐6‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₅H₂₂N₂O₄, (III), and 6‐tert‐butyl‐2‐(4‐methyl­phenyl)‐7‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₂H₂₆N₂O₂, (IV), were obtained from a stereospecific [3+2] 1,3‐cyclo­addition of 3‐methyl­ene azetidin‐2‐ones as dipolaro­philes with nitro­nes. The lactam ring is conjugated with the p‐­methoxy­phenyl or p‐methyl­phenyl moiety. The envelope conformations of the isoxazolidine rings in (III) and (IV) are different, leading the substituents to be pseudo‐axial in (III) and pseudo‐equatorial in (IV).     

4,4,6,6-Tetrachloro-2,2-(2,2-dimethylpropane-1,3-diyldioxy)-1,3,5,2λ5,4λ5,6λ5-triazatriphosphorine

The title spiro­cyclic compound (alternative name: 2,2,4,4-tetra­chloro-9,9-di­methyl-7,11-dioxa-1,3,5-tri­aza-2λ⁵,4λ⁵,6λ⁵-triphospha­spiro­[5.5]­undeca-1,3,5-triene), C₅H₁₀Cl₄N₃O₂P₃, does not contain alternating long–short P—N bond lengths in the phosphazene ring [P—N 1.559 (2)–1.596 (2) Å], as are observed in other analogous spiro­cyclic compounds. The six-membered phosphazene ring has a chair conformation in the solid state, but a conformational equilibrium in solution is indicated by NMR spectroscopy.     

Cinnamoyl shikonin

The title compound, 1-(5,8-di­hydro-1,4-di­hydroxy-5,8-dioxo-2-naphthyl)-4-methyl­pent-3-en-1-yl cinnamate, C₂₅H₂₂O₆, crystallizes in space group P2₁. The phenyl ring of the cinnamate is anti to the carbonyl group of the same moiety [C—C—C—C = −175.6 (2)°] and is nearly parallel to the naphthyl ring system. Two six-membered rings formed by intramolecular hydrogen bonds, with O—H⃛O distances of 2.587 (2) and 2.589 (2) Å, occur on either side of the fused ring system, creating a tetracyclic pyrene-shaped system. The phenyl ring forms an intermolecular stack with the benzo­quinone ring, as a result of aromatic π–π interactions.     

A 1,3,2‐ox­aza­borolidine dimer derived from (S)‐α,α‐di­phenyl­prolinol

The reaction of (S)‐α,α‐di­phenyl­prolinol with an excess of borane–tetra­hydro­furan complex yields a stable crystalline material with the composition C₃₄H₃₈B₂N₂O₂, which features a borane adduct of a spiro­cyclic structure with two ox­aza­borolidine rings joined by a central tetrahedral B atom. This dimeric ox­aza­borolidine complex, viz. 3,3,3′,3′‐tetra­phenyl‐1,1′‐spiro­bi(3a,4,5,6‐tetra­hydro‐3H‐pyrrolo­[1,2‐c][1,3,2]­ox­azaborole)–7‐borane, is the dominant product under various reaction conditions; its crystal structure is consistent with ¹¹B, ¹H and ¹³C NMR and IR analyses.     

2,4,6‐Tri­methyl­phenol

Crystals of the title compound, C₉H₁₂O, were formed as an unexpected by‐product during the recrystallization of (2R,3R)‐α,α,α′,α′‐tetramesityl‐1,4‐dioxa­spiro­[4,5]­decane‐2,3‐di­methanol from hexane/ethyl acetate (7:3). Strong hydrogen bonds between hydroxide groups connect the mol­ecules around one set of four symmetry‐equivalent 2₁ axes.     

Two natural products from the algae Laurencia scoparia

The structures and absolute stereochemistries of two chamigrene-type metabolites (spiro­[5.5]­un­decane derivatives) isolated from the red algae Laurencia scoparia are described. One, a non-sesquiterpene named ma?lione (8-bromo-9-hydroxy-7,7-di­methyl-11-methyl­ene­spiro­[5.5]­undec-1-en-3-one), C₁₄H₁₉BrO₂, was detected previously in Laurencia cartilaginea, while the other, the sesquiterpene isorigidol (8-bromo-3,7,7-tri­methyl-11-methyl­ene­spiro­[5.5]-undec-1-ene-3,9-diol), C₁₅H₂₃BrO₂, is a new isomer of rigidol, first isolated from Laurencia rigida. The A rings of these spiro­cyclic compounds show the same carbon skeleton. However, the relative stereochemistry of the 8-Br and 9-OH substituents is different. While ma?lione displays the usual syn (or cis) relative stereochemistry of the bromo­hydroxy vicinal group, isorigidol shows an anti (or trans) arrangement. The 8-Br and 9-OH groups are both in equatorial positions in isorigidol, while the 9-OH group is axial in ma?lione, as in most chamigrenes. The absolute configurations of the chiral centers were determined as 6S, 8S and 9R in ma?lione, and 3R, 6S, 8S and 9S in isorigidol.     

The 1:1 adduct of 5‐methylbenzene‐1,3‐diol (orcin) and 1,4‐di­aza­bicyclo­[2.2.2]­octane

In the title adduct, C₆H₁₂N₂·C₇H₈O₂, the orcin and 1,4‐di­aza­bi­cyclo­[2.2.2]­octane moieties are held together by O—H⋯N hydrogen bonds. One‐dimensional chiral hydrogen‐bonded chains are formed along the b axis. Neighbouring chains are held together principally by van der Waals interactions and are interrelated by translation, resulting in a chiral layer.     

Precursor of a β‐lactamase inhibitor: allyl (4S,8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.03,8]­undec‐2‐ene‐2‐carboxyl­ate

The molecular structure of the title tricyclic compound, C₁₇H₂₁NO₄, which is the immediate precursor of a potent synthetic inhibitor {Lek157: sodium (8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.0^3,8]­undec‐2‐ene‐2‐carboxyl­ate} with remarkable potency, provides experimental evidence for the previously modelled relative position of the fused cyclo­hexyl ring and the carbonyl group of the β‐lactam ring, which takes part in the formation of the initial tetrahedral acyl–enzyme complex. In this hydro­phobic mol­ecule, the overall geometry is influenced by C—H?O intramolecular hydrogen bonds [3.046 (4) and 3.538 (6) Å, with corresponding normalized H?O distances of 2.30 and 2.46 Å], whereas the mol­ecules are interconnected through intermolecular C—H?O hydrogen bonds [3.335 (4)–3.575 (5) Å].     

A spiro‐linked pyrene–naphtho­quinone

The title mol­ecule, 2′‐pyrenyl­spiro­[2,3‐di­hydro‐1H‐cyclo­penta­[b]­naphthalene‐2,5′‐1′,3′‐dioxane]‐4,9‐dione, C₃₂H₂₂O₄, contains an electron‐donating pyrene group spiro‐linked to an electron‐accepting naphtho­quinone. The mol­ecules are V‐shaped in profile and stack to form columns along b with alternating, approximately coplanar, pyrene and naphtho­quinone fragments. Intermolecular contacts within a column are consistent with some degree of π contact and possible long‐range delocalization. Individual columns form a herringbone pattern when the crystal is viewed along b .     

1H‐Pyrrolo[2,3‐b]pyridine‐3‐acetic acid as a molecular probe for use in auxin physiology

The structural characterization of 1H‐pyrrolo­[2,3‐b]­pyridine‐3‐acetic acid (alternative name: 7‐aza­indole‐3‐acetic acid), C₉H₈N₂O₂, reveals similar molecular geometry, i.e. with the side chain perpendicular to the 7‐aza­indole ring, to that of the natural plant growth hormone indole‐3‐acetic acid (auxin) and its alkyl­ated and halogenated derivatives.     

The 2:1 complex of maleic acid and 1,4‐diazabicyclo[2.2.2]octane: hydrogen‐bonded sheets linked by C–H⋯O hydrogen bonds

In the title complex, 1,4‐diazo­niabi­cyclo­[2.2.2]­octane bis­(hy­drogen maleate), C₆H₁₄N₂²⁺·2C₄H₃O₄^?, the C₄H₃O₄^? and C₆H₁₄N₂²⁺ ions, derived from maleic acid and 1,4‐di­aza­bi­cyclo­[2.2.2]­octane, respectively, are disordered across a mirror plane in space group Cmc2₁, and they are linked by two nearly linear N—H?O hydrogen bonds, with N?O distances of 2.662 (3) and 2.614 (4) Å, and N—H?O angles of 173°. The crystal structure consists of sheets with reticulations of 3.3792 (4) Å in stratum and 7.3892 (8) Å in width. The sheets are linked by C—H?O hydrogen bonds.     

Intermolecular stacking in pyrazolo[3,4‐d]pyrimidine‐based pentamethylene‐linked flexible ­molecules

The crystal structures of 1‐{5‐[4,6‐bis­(methyl­sulfanyl)‐2H‐py­razolo­[3,4‐d]­pyrimidin‐2‐yl]­pentyl}‐6‐methyl­sulfanyl‐4‐(pyr­rolidin‐1‐yl)‐1H‐pyrazolo­[3,4‐d]­pyrimidine, C₂₂H₂₉N₉S₃, and 6‐methyl­sulfanyl‐1‐{5‐[6‐methyl­sulfanyl‐4‐(pyrrolidin‐1‐yl)‐2H‐pyrazolo­[3,4‐d]­pyrimidin‐2‐yl]­pentyl}‐4‐(pyrrolidin‐1‐yl)‐1H‐pyrazolo­[3,4‐d]­pyrimidine, C₂₅H₃₄N₁₀S₂, which differ in having either a pyrrolidine substituent or a methylsulfanyl group, show intermolecular stacking due to aromatic π–π interactions between the pyrazolo­[3,4‐d]­pyrimidine rings.     

25,27‐(6‐Tosyl‐3,9‐dioxa‐6‐aza­un­decane‐1,11‐diyldioxy)‐26,28‐(3,6,9‐trioxaun­decane‐1,11‐diyldioxy)­calix­[4]­arene

A new calix­[4]‐­crowned aza­crown ether, C₅₁H₅₉NO₁₁S, consisting of four phenyl rings in a 1,3‐alternate conformation was synthesized from the reaction of 25,27‐bis(5‐chloro‐3‐oxa­pentyl­oxy)­calix­[4]­crown‐5 and p‐toluene­sulfon­amide in the presence of Cs₂CO₃. A crown‐5 loop was attached on the two facing lower rims of the calix­[4]­arene and the N‐tosyl aza­crown group was attached on the other set of lower rims of the calix­[4]­arene backbone. This mol­ecule seems to offer an inside cavity for the formation of a host–guest complex.     

Di­spiro­[fluorene‐9,5′‐[1,2,3,4]­tetra­thia­ne‐6′,9′′‐fluorene]

The tetra­thia­ne ring of the title compound, C₂₆H₁₆S₄, has a chair conformation and the mol­ecule has approximate C₂ symmetry. Each of the two fluorene ring systems is virtually planar, with the ring planes intersecting at an angle of 67.58 (5)°. This novel compound has been formed as a side product from the treatment of 9H‐fluorene‐9‐thione with methyl N‐[(benzyl­idene)­phenyl]­glycinate in the presence of LiBr and 1,6‐di­aza­bi­cyclo­[5.4.0]­un­decane.     

25,27:26,28‐Bis(3,9‐dioxa‐6‐aza­undecane‐1,11‐dioxy)­calix­[4]­arene tetrahydrate

The title compound, C₄₄H₅₄N₂O₈·4H₂O, has twofold crystallographic symmetry and consists of a calix­[4]­arene moiety with four phenyl rings arranged alternately in anti‐orientation fashion and two aza­crown units attached on the lower rims of calix­[4]­arene. This seems to offer a big cavity inside the mol­ecule which might possess a potential for forming host–guest complexes.